Christopher Peters

Christopher Peters is a Clinical Associate Professor in the Upper GI Department at Imperial College London's Faculty of Medicine. He holds dual roles as a Clinical Senior Lecturer and Honorary Consultant Upper GI and General Surgeon at Imperial College Healthcare NHS Trust. His research focuses on translating biomarkers and diagnostic technologies into clinical practice, including developing the Biomarker Toolkit and advancing intraoperative cancer detection via diffuse reflectance spectroscopy. He leads the NIHR-funded PICCOS trial exploring pressurised intraperitoneal chemotherapy.

• Affiliations: NIHR HealthTech Research Centre (HRC), CRUK Convergence Science Centre

Education:

• BSc in Clinical Sciences, University of Leeds (2009-2010)
• MBChB, University of Leeds (1996-2002)
• PhD in Oncology, University of Cambridge (2006-2010)

Research Interests: Biomarker validation, surgical precision technologies, and gastrointestinal oncology. His work bridges biomarker discovery with clinical application, exemplified by the OCCAMS collaboration, which recruited over 4,000 patients and produced 35+ publications in journals like Nature and Nature Genetics.

Grants & Trials: Leads the NIHR-funded PICCOS trial and co-leads the NIHR HRC In-vitro Diagnostics initiative. His work has been supported by CRUK and the International Cancer Genome Consortium.

Labs & Teams: Academic Department of Surgery at Hammersmith Hospital, collaborating with Professor Dan Elson on optical spectroscopy and Professor Rebecca Fitzgerald on esophageal cancer genomics.